Why the study?
Does routine measurement of urine albumin-to-creatinine ratio improve the detection of chronic kidney disease in patients with cardiometabolic risk factors?
Cross-Sectional (n=300)
No
Does routine measurement of urine albumin-to-creatinine ratio improve the detection of chronic kidney disease in patients with cardiometabolic risk factors?
Answers are grounded in this paper and cite their sources.
Routine screening of the albumin-to-creatinine ratio identifies a significant proportion of patients with early-stage chronic kidney disease who have preserved eGFR, allowing for timely initiation of nephroprotective therapies like SGLT2 inhibitors.
Based on our own practical experience and data from scientific literature, we can assert that measuring the ratio of albumin to creatinine and calculating the glomerular filtration rate are important tools for the timely diagnosis of chronic kidney disease (CKD), monitoring treatment effectiveness, and determining the dynamics of a patient’s renal condition. Early diagnosis of CKD allows us to take necessary measures to slow down or even halt the progression of the disease. By timely administering nephroprotective drugs, such as SGLT-2 inhibitors, we can improve the prognosis and quality of life for patients, which holds medical, social, and economic significance.
No takes yet. Share an insight, caveat, or question.
Sayenko et al. (2023) conducted a cross-sectional in Type 2 diabetes, arterial hypertension, and cardiovascular diseases (n=300). Albumin-to-creatinine ratio and eGFR screening was evaluated on Correlation between estimated glomerular filtration rate (eGFR) and albuminuria (r = -0.16, p=0.03).
Synapse has enriched 10 related papers. Consider them for comparative context: